Amazing Brains: Research to Recovery. Previously known as our Keynote Lecture, our event took place on Wednesday, 15 May 2019, at the Science Museum in central London.
Our policy positions set out in detail where we stand on big issues that affect stroke survivors and the wider world of stroke.
The Stroke Association reserves the right to make changes to these terms and conditions at any time.
Regularly drinking large amounts of alcohol greatly increases your risk of stroke. But there are tools that can help you track how much you're drinking and cut down if you need to, and support with reducing your drinking.
This research looks to understand if a new technological device, the Neuroplatform, can improve arm and hand movement in stroke survivors at early stages of their recovery.
Many stroke survivors use art in their recovery and each year, through our Christmas Card Competition, a stroke survivor’s artwork is made into a limited edition Christmas card and sold in our range to raise vital funds for stroke survivors across the UK.
The first day of the European Stroke Organisation Conference (ESOC) 2017 in Prague included some truly inspiring scientific sessions. These included reporting from the DAWN study which suggests that more patients could be able to receive mechanical thrombectomy after stroke.
The International Stroke Conference (ISC) is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take homes from our International Development Officer, Sarah Belson.
To help plan the care of stroke survivors and their rehabilitation, health professionals usually use a scale called the Barthel Index (BI) to measure how well they can perform activites of daily living (ADLs).
Visual field loss is a commonly reported side effect of stroke and can seriously impact on functional ability and quality of life. Published today in the journal, Neuro-Ophthalmology, a new study shares insights learned from recruitment of study participants to the 'VISION' trial, and how this may inform future, similar trials.